Also trades as: 0IL8.L (LSE) · $vol 0M
KYNB NASDAQ
Kyntra Bio, Inc.
1W: -9.1%
1M: -26.0%
3M: -13.0%
YTD: -31.1%
$6.31
-0.19 (-2.92%)
Weekly Expected Move ±4.5%
$6
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Moderate
50
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$25.5M
52W Range6.3-12.13
Volume26,079
Avg Volume20,775
Beta1.06
Dividend—
Analyst Ratings
Company Info
CEOThane Wettig
Employees34
SectorHealthcare
IndustryBiotechnology
IPO Date2014-11-14
Websitekyntrabio.com
350 Bay Street
San Francisco, CA 94133
US
San Francisco, CA 94133
US
415 978 1200
About Kyntra Bio, Inc.
Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to create groundbreaking therapies aimed at tackling conditions like anemia, various fibrotic disorders, and different forms of cancer. Established by Thomas B. Neff on September 29, 1993, the firm's main offices are situated in San Francisco, California.
Latest News
Kyntra Bio (KYNB) Q2 2026 Earnings Call Transcript
Kyntra Bio targets FG-3246 median rPFS of 10 months or greater as it plans roxadustat Phase III start in Q4 2026
Kyntra Bio (KYNB) Reports Q2 Loss, Lags Revenue Estimates
Kamada (KMDA) Q2 Earnings and Revenues Surpass Estimates
Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: Should You Buy?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Wettig Thane | F-InKind | 209 | $8.55 | 2026-09-06 |
| DeLucia David | F-InKind | 22 | $8.55 | 2026-09-06 |
| Ho Maykin | A-Award | 7,000 | $7.13 | 2026-06-12 |
| EDWARDS JEFFREY L | A-Award | 7,000 | $7.13 | 2026-06-12 |
| Kauffman Michael | A-Award | 7,000 | $7.13 | 2026-06-12 |